These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 28898467)

  • 21. Mohs micrographic surgery of rare cutaneous tumours.
    Flohil SC; van Lee CB; Beisenherz J; Mureau MAM; Overbeek LIH; Nijsten T; van den Bos RR
    J Eur Acad Dermatol Venereol; 2017 Aug; 31(8):1285-1288. PubMed ID: 27976423
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mohs micrographic surgery for basal cell carcinoma: evaluation of the indication criteria and predictive factors for extensive subclinical spread.
    Hoorens I; Batteauw A; Van Maele G; Lapiere K; Boone B; Ongenae K
    Br J Dermatol; 2016 Apr; 174(4):847-52. PubMed ID: 26595159
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cutaneous lip tumours treated with Mohs micrographic surgery: clinical features and surgical outcome.
    Leibovitch I; Huilgol SC; Selva D; Paver R; Richards S
    Br J Dermatol; 2005 Dec; 153(6):1147-52. PubMed ID: 16307650
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A prospective study of Mohs' micrographic surgery in two English centres.
    Julian CG; Bowers PW
    Br J Dermatol; 1997 Apr; 136(4):515-8. PubMed ID: 9155950
    [TBL] [Abstract][Full Text] [Related]  

  • 25. State of the art of Mohs surgery for rare cutaneous tumors in the Spanish Registry of Mohs Surgery (REGESMOHS).
    Rodríguez-Jiménez P; Jimenez YD; Reolid A; Sanmartın-Jimenez O; Garces JR; Rodríguez-Prieto MA; Medrano RM; Vilarrasa E; de Eusebio-Murillo E; Redondo P; Ciudad-Blanco C; Morales-Gordillo V; Toll-Abelló A; Artola-Igarza JL; Pacheco MLA; Markixana IA; Fernández RS; Rubio AA; Vázquez-Veiga H; Flórez-Menéndez A; de la Cueva Dobao P; Botella-Estrada R; Garcia-Bracamonte B; Carnero-González L; Ruiz-Salas V; Sánchez-Sambucety P; López-Estebaranz JL; Gil P; Barchino L; Arenal MM; Ocerin-Guerra I; Hueso L; Seoane-Pose MJ; Gonzalez-Sixto B; Cano-Martinez N; Escutia-Muñoz B; Ortiz-Romero PL; Garcia-Doval I; Descalzo MA;
    Int J Dermatol; 2020 Mar; 59(3):321-325. PubMed ID: 31777957
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical outcomes in high-risk squamous cell carcinoma patients treated with Mohs micrographic surgery alone.
    Marrazzo G; Zitelli JA; Brodland D
    J Am Acad Dermatol; 2019 Mar; 80(3):633-638. PubMed ID: 30244064
    [TBL] [Abstract][Full Text] [Related]  

  • 27. National utilization patterns of Mohs micrographic surgery for invasive melanoma and melanoma in situ.
    Viola KV; Rezzadeh KS; Gonsalves L; Patel P; Gross CP; Yoo J; Stamell E; Turner RB
    J Am Acad Dermatol; 2015 Jun; 72(6):1060-5. PubMed ID: 25824274
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Basosquamous carcinoma and metatypical basal cell carcinoma: a review of treatment with Mohs micrographic surgery.
    Allen KJ; Cappel MA; Killian JM; Brewer JD
    Int J Dermatol; 2014 Nov; 53(11):1395-403. PubMed ID: 24961583
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tumor characteristics of Mohs surgery patients in Ottawa, Canada versus Houston, Texas--a consequence of access to care?
    Beach RA; Zhang T; Goldberg LH; Walker JD; Mamelak AJ
    Dermatol Surg; 2011 Aug; 37(8):1106-12. PubMed ID: 21635629
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Basal cell carcinoma treated with Mohs surgery in Australia II. Outcome at 5-year follow-up.
    Leibovitch I; Huilgol SC; Selva D; Richards S; Paver R
    J Am Acad Dermatol; 2005 Sep; 53(3):452-7. PubMed ID: 16112352
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Basal cell carcinoma treated with Mohs surgery in Australia I. Experience over 10 years.
    Leibovitch I; Huilgol SC; Selva D; Richards S; Paver R
    J Am Acad Dermatol; 2005 Sep; 53(3):445-51. PubMed ID: 16112351
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Scalp tumors treated with Mohs micrographic surgery: clinical features and surgical outcome.
    Leibovitch I; Huilgol SC; Richards S; Paver R; Selva D
    Dermatol Surg; 2006 Nov; 32(11):1369-74. PubMed ID: 17083590
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Low recurrence rates for in situ and invasive melanomas using Mohs micrographic surgery with melanoma antigen recognized by T cells 1 (MART-1) immunostaining: tissue processing methodology to optimize pathologic staging and margin assessment.
    Etzkorn JR; Sobanko JF; Elenitsas R; Newman JG; Goldbach H; Shin TM; Miller CJ
    J Am Acad Dermatol; 2015 May; 72(5):840-50. PubMed ID: 25774012
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adverse events associated with mohs micrographic surgery: multicenter prospective cohort study of 20,821 cases at 23 centers.
    Alam M; Ibrahim O; Nodzenski M; Strasswimmer JM; Jiang SI; Cohen JL; Albano BJ; Batra P; Behshad R; Benedetto AV; Chan CS; Chilukuri S; Crocker C; Crystal HW; Dhir A; Faulconer VA; Goldberg LH; Goodman C; Greenbaum SS; Hale EK; Hanke CW; Hruza GJ; Jacobson L; Jones J; Kimyai-Asadi A; Kouba D; Lahti J; Macias K; Miller SJ; Monk E; Nguyen TH; Oganesyan G; Pennie M; Pontius K; Posten W; Reichel JL; Rohrer TE; Rooney JA; Tran HT; Poon E; Bolotin D; Dubina M; Pace N; Kim N; Disphanurat W; Kathawalla U; Kakar R; West DP; Veledar E; Yoo S
    JAMA Dermatol; 2013 Dec; 149(12):1378-85. PubMed ID: 24080866
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mohs versus surgical excision in nonmelanoma skin cancers: does location matter?
    Pereira CT; Kruger EA; Sayer G; Kim J; Hu J; Miller TA; Rudkin GH
    Ann Plast Surg; 2013 Apr; 70(4):432-4. PubMed ID: 23486132
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Periocular Mohs micrographic surgery in Western Australia 2009-2012: A single centre retrospective review and proposal for practice benchmarks.
    O'Halloran L; Smith H; Vinciullo C
    Australas J Dermatol; 2017 May; 58(2):106-110. PubMed ID: 26767931
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Life expectancy after Mohs micrographic surgery in patients aged 90 years and older.
    Delaney A; Shimizu I; Goldberg LH; MacFarlane DF
    J Am Acad Dermatol; 2013 Feb; 68(2):296-300. PubMed ID: 23200199
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Imiquimod 5% cream as pretreatment of Mohs micrographic surgery for nodular basal cell carcinoma in the face: a prospective randomized controlled study.
    van der Geer S; Martens J; van Roij J; Brand E; Ostertag JU; Verhaegh ME; Neumann HA; Krekels GA
    Br J Dermatol; 2012 Jul; 167(1):110-5. PubMed ID: 22385074
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mohs micrographic surgery in immunosuppressed vs immunocompetent patients: Results of a prospective nationwide cohort study (REGESMOHS, Spanish registry of Mohs surgery).
    Abril-Pérez C; Mansilla-Polo M; Escutia-Muñoz B; Sanmartín O; Garcés JR; Rodríguez-Prieto MA; Ruiz-Salas V; de Eusebio-Murillo E; Miñano-Medrano R; González-Sixto B; Artola-Igarza JL; Alfaro-Rubio A; Redondo P; Delgado-Jiménez Y; Sánchez-Schmidt JM; Allende-Markixana I; Alonso-Pacheco ML; García-Bracamonte B; de la Cueva-Dobao P; Navarro-Tejedor R; Ciudad-Blanco C; Carnero-González L; Vázquez-Veiga H; Cano-Martínez N; Serra-Guillén C; Vilarrasa E; Sánchez-Sambucety P; López-Estebaranz JL; Flórez-Menéndez Á; Martorell-Calatayud A; Gil P; Morales-Gordillo V; Toll A; Ocerin-Guerra I; Mayor-Arenal M; Suárez-Fernández R; Sainz-Gaspar L; Descalzo MA; Garcia-Doval I; Botella-Estrada R;
    J Eur Acad Dermatol Venereol; 2024 May; ():. PubMed ID: 38733285
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Incompletely excised basal cell carcinoma: residual tumor rates at Mohs re-excision.
    Palmer VM; Wilson PR
    Dermatol Surg; 2013 May; 39(5):706-18. PubMed ID: 23294110
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.